Literature DB >> 4994393

Antinuclear antibodies, rheumatoid factor and C-reactive protein in serum of normal women using oral contraceptives.

D R Kay, G G Bole, W J Ledger.   

Abstract

Entities:  

Keywords:  Americas; Antibodies; Autoantibodies; Biology; Chlormadinone Acetate; Comparative Studies; Contraception; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods--side effects; Developed Countries; Ethinyl Estradiol; Ethynodiol Diacetate; Family Planning; Hematological Effects; Hemic System; Immunity; Immunoglobulin Alterations; Immunologic Factors; Mestranol; Michigan; Norethindrone; Norethindrone Acetate; Norethynodrel; North America; Northern America; Oral Contraceptives, Combined; Oral Contraceptives, Phasic; Oral Contraceptives--side effects; Physiology; Prospective Studies; Research Methodology; Rheumatoid Factor; Serum Protein Effects; Studies; United States

Mesh:

Substances:

Year:  1971        PMID: 4994393     DOI: 10.1002/art.1780140208

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


× No keyword cloud information.
  5 in total

1.  Erythema nodosum associated with pregnancy and oral contraceptives.

Authors:  S Bombardieri; O D Munno; C Di Punzio; G Pasero
Journal:  Br Med J       Date:  1977-06-11

2.  Relation of titred peripheral pattern ANA to anti-DNA and disease activity in systemic lupus erythematosus.

Authors:  R J Weitzman; S E Walker
Journal:  Ann Rheum Dis       Date:  1977-02       Impact factor: 19.103

Review 3.  Recent advances in the immunopathogenesis of systemic lupus erythematosus.

Authors:  E J Bardana; B Pirofsky
Journal:  West J Med       Date:  1975-02

4.  Acute phase serum proteins in syngeneic and allogeneic mouse pregnancy.

Authors:  G T Waites; A M Bell; S C Bell
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

5.  Systemic inflammation is associated with ovarian follicular dynamics during the human menstrual cycle.

Authors:  Kathryn B H Clancy; Angela R Baerwald; Roger A Pierson
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.